Literature DB >> 28621175

In vivo investigation of tissue-engineered periosteum for the repair of allogeneic critical size bone defects in rabbits.

Lin Zhao1, Junli Zhao2, Jiajia Yu3, Rui Sun3, Xiaofeng Zhang1, Shuhua Hu1.   

Abstract

AIM: The aim of the study was to evaluate the efficacy of tissue-engineered periosteum (TEP) in repairing allogenic bone defects in the long term. MATERIALS &
METHODS: TEP was biofabricated with osteoinduced rabbit bone marrow mesenchymal stem cells and porcine small intestinal submucosa (SIS). A total of 24 critical sized defects were created bilaterally in radii of 12 New Zealand White rabbits. TEP/SIS was implanted into the defect site. Bone defect repair was evaluated with radiographic and histological examination at 4, 8 and 12 weeks.
RESULTS: Bone defects were structurally reconstructed in the TEP group with mature cortical bone and medullary canals, however this was not observed in the SIS group at 12 weeks.
CONCLUSION: The TEP approach can effectively restore allogenic critical sized defects, and achieve maturity of long-bone structure in 12 weeks in rabbit models.

Entities:  

Keywords:  allograft; bone defect; bone tissue engineering; in vivo bioreactor; rabbit

Mesh:

Year:  2017        PMID: 28621175     DOI: 10.2217/rme-2016-0157

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  4 in total

1.  Orthogonal test design for the optimization of superparamagnetic chitosan plasmid gelatin microspheres that promote vascularization of artificial bone.

Authors:  Chen Tao; Xie Lina; Wang Changxuan; Luo Cong; Yang Xiaolan; Huang Tao; An Hong
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-10-12       Impact factor: 3.368

2.  Repair of long bone defects of large size using a tissue-engineered periosteum in a rabbit model.

Authors:  Lin Zhao; Junli Zhao; Zhenhe Tuo; Guangtie Ren
Journal:  J Mater Sci Mater Med       Date:  2021-08-21       Impact factor: 3.896

Review 3.  Recent advances in bioreactors for cell-based therapies.

Authors:  Makeda Stephenson; Warren Grayson
Journal:  F1000Res       Date:  2018-04-30

4.  Irregular Bone Defect Repair Using Tissue-Engineered Periosteum in a Rabbit Model.

Authors:  Lin Zhao; Junli Zhao; Jia-Jia Yu; Cangyu Zhang
Journal:  Tissue Eng Regen Med       Date:  2020-09-10       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.